Health Care & Life Sciences » Pharmaceuticals | Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd.
Stock Exchange London Stock Exchange
EPS
 GBP0.08
Market Cap
 GBP2.45 B
Shares Outstanding
 666.58 M
Public Float
 21.83 M
Hutchison China MediTech Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
 $0.06
Market Cap
 $30.09 B
Shares Outstanding
 133.32 M
Public Float
 -

Profile

Address
Cheung Kong Center
Hong Kong
Hong Kong
Employees -
Website http://www.chi-med.com
Updated 07/08/2019
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases.

Financials

View All
Created with Highcharts 5.0.14Hutchison China MediTech Ltd.Net Income. Fiscal year is January-December. All values GBP Thousands.5 0495 04920 54720 54722 91322 9138 6698 66920 76120 76156 10056 100201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Hutchison China MediTech Ltd.Sales/Revenue. Fiscal year is January-December. All values GBP Thousands.29 40929 40953 03753 037116 640116 640160 142160 142187 295187 295160 573160 573201320142015201620172018050k100k150k200k

Chi Keung To
Chairman
Christian Hogg
Chief Executive Officer & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.